Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2002 2
2003 2
2004 3
2005 5
2006 9
2007 24
2008 36
2009 99
2010 164
2011 298
2012 550
2013 645
2014 651
2015 665
2016 699
2017 733
2018 648
2019 551
2020 570
2021 550
2022 436
2023 340
2024 135

Text availability

Article attribute

Article type

Publication date

Search Results

6,910 results

Results by year

Filters applied: . Clear all
Page 1
Pradaxa-induced esophageal ulcer.
Wood M, Shaw P. Wood M, et al. BMJ Case Rep. 2015 Oct 9;2015:bcr2015211371. doi: 10.1136/bcr-2015-211371. BMJ Case Rep. 2015. PMID: 26452739 Free PMC article.
Pradaxa (dabigatran) is a direct thrombin inhibitor approved for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation. We describe a case of esophageal ulceration associated with Pradaxa administration in a 75-year-old …
Pradaxa (dabigatran) is a direct thrombin inhibitor approved for prevention of stroke and systemic embolism in patients with n …
Dabigatran (Pradaxa()): surgeon's friend or foe?
Syyed N, Ansell M, Sood V. Syyed N, et al. Br Dent J. 2014 Dec 5;217(11):623-6. doi: 10.1038/sj.bdj.2014.1051. Br Dent J. 2014. PMID: 25476635 Review.
Therefore, it is imperative that clinicians are aware of the risks and benefits associated with dabigatran....
Therefore, it is imperative that clinicians are aware of the risks and benefits associated with dabigatran....
Direct oral anticoagulants: evidence and unresolved issues.
Chan N, Sobieraj-Teague M, Eikelboom JW. Chan N, et al. Lancet. 2020 Nov 28;396(10264):1767-1776. doi: 10.1016/S0140-6736(20)32439-9. Lancet. 2020. PMID: 33248499 Review.
Currently licenced direct oral anticoagulants selectively target thrombin (eg, dabigatran) or coagulation factor Xa (eg, apixaban, betrixaban, edoxaban, and rivaroxaban). ...
Currently licenced direct oral anticoagulants selectively target thrombin (eg, dabigatran) or coagulation factor Xa (eg, apixaban, be …
Idarucizumab for Dabigatran Reversal - Full Cohort Analysis.
Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI. Pollack CV Jr, et al. N Engl J Med. 2017 Aug 3;377(5):431-441. doi: 10.1056/NEJMoa1707278. Epub 2017 Jul 11. N Engl J Med. 2017. PMID: 28693366 Free article. Clinical Trial.
BACKGROUND: Idarucizumab, a monoclonal antibody fragment, was developed to reverse the anticoagulant effect of dabigatran. METHODS: We performed a multicenter, prospective, open-label study to determine whether 5 g of intravenous idarucizumab would be able to reverse the a …
BACKGROUND: Idarucizumab, a monoclonal antibody fragment, was developed to reverse the anticoagulant effect of dabigatran. METHODS: W …
Splenic rupture.
Fegan D. Fegan D. Clin Med (Lond). 2019 Mar;19(2):188-189. doi: 10.7861/clinmedicine.19-2-188. Clin Med (Lond). 2019. PMID: 30872308 Free PMC article. No abstract available.
Dabigatran (Pradaxa) Is Safe for Extended Venous Thromboembolism Prophylaxis After Surgery for Pancreatic Cancer.
Rashid MF, Jackson TL, Morgan JA, Dwyer FA, Schrope BA, Chabot JA, Kluger MD. Rashid MF, et al. J Gastrointest Surg. 2019 Jun;23(6):1166-1171. doi: 10.1007/s11605-018-3936-1. Epub 2018 Sep 5. J Gastrointest Surg. 2019. PMID: 30187331
RESULTS: A total of 134 patients were considered for this study (median age 67 10; 58.9% male). Eighty-seven (82.9%) patients received dabigatran and 18 (17.1%) received another form of anticoagulation. There were 19 (4.2%) patients not prescribed dabigatran due to …
RESULTS: A total of 134 patients were considered for this study (median age 67 10; 58.9% male). Eighty-seven (82.9%) patients received da …
Dabigatran-induced esophagitis.
Kajihara Y. Kajihara Y. Cleve Clin J Med. 2019 May;86(5):303-304. doi: 10.3949/ccjm.86a.18117. Cleve Clin J Med. 2019. PMID: 31066667 Free article. No abstract available.
How I treat pediatric venous thromboembolism in the DOAC era.
Bhat RV, Young G, Sharathkumar AA. Bhat RV, et al. Blood. 2024 Feb 1;143(5):389-403. doi: 10.1182/blood.2022018966. Blood. 2024. PMID: 37390311 Free PMC article.
The direct oral anticoagulants (DOACs) rivaroxaban and dabigatran are newly licensed for the treatment and prevention of venous thromboembolism (VTE) in children and mark a renaissance in pediatric anticoagulation management. ...
The direct oral anticoagulants (DOACs) rivaroxaban and dabigatran are newly licensed for the treatment and prevention of venous throm …
6,910 results

Searches related to "pradaxa"